Post-translational modification patterns on β-myosin heavy chain are altered in ischemic and non-ischemic human hearts
- Florida State University, United States
- University of Washington, United States
- The Ohio State University, United States
- Ohio State University, United States
Abstract
Phosphorylation and acetylation of sarcomeric proteins are important for fine-tuning myocardial contractility. Here, we used bottom-up proteomics and label-free quantification to identify novel post-translational modifications (PTMs) on beta-myosin heavy chain (b-MHC) in normal and failing human heart tissues. We report six acetylated lysines and two phosphorylated residues: K34-Ac, K58-Ac, S210-P, K213-Ac, T215-P, K429-Ac, K951-Ac, and K1195-Ac. K951-Ac was significantly reduced in both ischemic and non-ischemic failing hearts compared to non-diseased hearts. Molecular dynamics simulations show that K951-Ac may impact stability of thick filament tail interactions and ultimately myosin head positioning. K58-Ac altered the solvent exposed SH3 domain surface - known for protein-protein interactions - but did not appreciably change motor domain conformation or dynamics under conditions studied. Together, K213-Ac/T215-P altered loop 1's structure and dynamics - known to regulate ADP-release, ATPase activity, and sliding velocity. Our study suggests that β-MHC acetylation levels may be influenced more by the PTM location than the type of heart disease since less protected acetylation sites are reduced in both heart failure groups. Additionally, these PTMs have potential to modulate interactions between β-MHC and other regulatory sarcomeric proteins, ADP-release rate of myosin, flexibility of the S2 region, and cardiac myofilament contractility in normal and heart failure hearts.
Data availability
All data generated or analyzed during this study are included in the manuscript and the supporting files have been provided for Figures 2, 3, 7, 8 , 9 and Supplemental Figure 1, 2, 4, Tables 1, 2, 3 and 4.Mass spec data have been deposited at Dryad under the unique identifier DOI (doi:10.5061/dryad.s4mw6m97g).
-
Data from: Post-translational modification patterns on β-myosin heavy chain are altered in ischemic and non-ischemic human heartsDryad Digital Repository, doi:10.5061/dryad.s4mw6m97g.
Article and author information
Author details
Matthew C Childers
Michelle S Parvatiyar
Funding
American Heart Association (16SDG2912000)
- Michelle S Parvatiyar
Florida State University (46259)
- Michelle S Parvatiyar
National Institutes of Health (HL128683)
- Jose R Pinto
American Heart Association (2021AHAPRE216237)
- Maicon Landim-Vieira
National Science Foundation (ACI-1548562)
- Michael Regnier
National Institutes of Health (T32HL007828)
- Matthew C Childers
National Institutes of Health (P30AR074990)
- Michael Regnier
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Christopher L-H Huang, University of Cambridge, United Kingdom
Ethics
Human subjects: This study was conducted with the highest ethical standards, human heart samples were collected and stored with full consent of parties involved and were provided by the Lifeline of Ohio with coordination from surgeons and transplant coordinators at the Ohio State University Wexner Medical Center. All aspects of this study were approved and conform to the ethical guidelines established by the Institutional Review Board of The Ohio State University under protocol #2012H0197.
Version history
- Received: October 21, 2021
- Preprint posted: November 22, 2021 (view preprint)
- Accepted: May 1, 2022
- Accepted Manuscript published: May 3, 2022 (version 1)
- Version of Record published: May 20, 2022 (version 2)
Copyright
© 2022, Landim-Vieira et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,505
- views
-
- 254
- downloads
-
- 10
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Post-translational modification patterns on β-myosin heavy chain are altered in ischemic and non-ischemic human hearts
eLife 11:e74919.
https://doi.org/10.7554/eLife.74919
Further reading
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
The type II class of RAF inhibitors currently in clinical trials paradoxically activate BRAF at subsaturating concentrations. Activation is mediated by induction of BRAF dimers, but why activation rather than inhibition occurs remains unclear. Using biophysical methods tracking BRAF dimerization and conformation, we built an allosteric model of inhibitor-induced dimerization that resolves the allosteric contributions of inhibitor binding to the two active sites of the dimer, revealing key differences between type I and type II RAF inhibitors. For type II inhibitors the allosteric coupling between inhibitor binding and BRAF dimerization is distributed asymmetrically across the two dimer binding sites, with binding to the first site dominating the allostery. This asymmetry results in efficient and selective induction of dimers with one inhibited and one catalytically active subunit. Our allosteric models quantitatively account for paradoxical activation data measured for 11 RAF inhibitors. Unlike type II inhibitors, type I inhibitors lack allosteric asymmetry and do not activate BRAF homodimers. Finally, NMR data reveal that BRAF homodimers are dynamically asymmetric with only one of the subunits locked in the active αC-in state. This provides a structural mechanism for how binding of only a single αC-in inhibitor molecule can induce potent BRAF dimerization and activation.
-
- Structural Biology and Molecular Biophysics
We integrate evolutionary predictions based on the neutral theory of molecular evolution with protein dynamics to generate mechanistic insight into the molecular adaptations of the SARS-COV-2 spike (S) protein. With this approach, we first identified candidate adaptive polymorphisms (CAPs) of the SARS-CoV-2 S protein and assessed the impact of these CAPs through dynamics analysis. Not only have we found that CAPs frequently overlap with well-known functional sites, but also, using several different dynamics-based metrics, we reveal the critical allosteric interplay between SARS-CoV-2 CAPs and the S protein binding sites with the human ACE2 (hACE2) protein. CAPs interact far differently with the hACE2 binding site residues in the open conformation of the S protein compared to the closed form. In particular, the CAP sites control the dynamics of binding residues in the open state, suggesting an allosteric control of hACE2 binding. We also explored the characteristic mutations of different SARS-CoV-2 strains to find dynamic hallmarks and potential effects of future mutations. Our analyses reveal that Delta strain-specific variants have non-additive (i.e., epistatic) interactions with CAP sites, whereas the less pathogenic Omicron strains have mostly additive mutations. Finally, our dynamics-based analysis suggests that the novel mutations observed in the Omicron strain epistatically interact with the CAP sites to help escape antibody binding.
